Clinical Scorecard: Look Beyond the Bottle in Glaucoma Care
At a Glance
Category
Detail
Condition
Glaucoma
Key Mechanisms
Interventional glaucoma approaches, including minimally invasive surgery and sustained-release drug delivery, improve IOP control and patient adherence.
Target Population
Patients with glaucoma, particularly those struggling with adherence to topical therapies.
Care Setting
Ophthalmology clinics
Key Highlights
90% of patients do not adhere to prescribed drop schedules.
Interventional glaucoma approaches can improve quality of life and IOP stabilization.
Minimally invasive glaucoma surgery (MIGS) has a better safety profile than traditional surgery.
Early selective laser trabeculoplasty (SLT) shows excellent IOP control with less vision field loss.
Sustained-release drug delivery devices eliminate the reliance on patient adherence.
Guideline-Based Recommendations
Diagnosis
Regular monitoring of IOP and visual fields is essential for glaucoma management.
Management
Consider interventional glaucoma approaches earlier in the treatment algorithm.
Monitoring & Follow-up
Patients should be followed up regularly to prevent vision loss.
Risks
Nonadherence to topical therapy can lead to faster disease progression and severe vision loss.
Patient & Prescribing Data
Patients with primary open-angle glaucoma and those at risk of nonadherence.
Sustained-release implants and MIGS can provide effective IOP control without relying on patient compliance.
Clinical Best Practices
Utilize interventional glaucoma techniques to enhance patient outcomes.
Educate patients on the importance of regular follow-up and adherence to treatment.
Implement a treatment plan that considers the patient's ability to adhere to therapy.
Ophthalmologists caring for adults with this condition may encounter persistent inflammation, treatment dependence, and the cumulative ocular effects of childhood disease.
